A detailed history of Bayesian Capital Management, LP transactions in Abbott Laboratories stock. As of the latest transaction made, Bayesian Capital Management, LP holds 14,600 shares of ABT stock, worth $1.51 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
14,600
Previous 55,544 73.71%
Holding current value
$1.51 Million
Previous $6.11 Million 72.86%
% of portfolio
0.16%
Previous 0.66%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $4.48 Million - $4.95 Million
-40,944 Reduced 73.71%
14,600 $1.66 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $4.5 Million - $5.51 Million
49,944 Added 891.86%
55,544 $6.11 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $2.67 Million - $3.2 Million
-27,900 Reduced 83.28%
5,600 $542,000
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $3.38 Million - $3.76 Million
33,500 New
33,500 $3.65 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $290,280 - $336,090
3,000 New
3,000 $290,000
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $2.15 Million - $2.63 Million
-18,609 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $2.17 Million - $2.4 Million
18,609 New
18,609 $2.2 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $402,708 - $474,450
-3,700 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $1.06 Million - $1.16 Million
-10,100 Reduced 73.19%
3,700 $405,000
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $1.26 Million - $1.54 Million
13,800 New
13,800 $1.5 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $474,996 - $574,270
-7,173 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $470,261 - $532,738
7,173 New
7,173 $519,000
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $659,119 - $795,149
-10,839 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $2.5 Million - $2.76 Million
-43,500 Reduced 80.05%
10,839 $661,000
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $3.06 Million - $3.46 Million
54,339 New
54,339 $3.26 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $181B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.